in this issue
Chemical Week Magazine :: Newsbriefs
Private Equity Firms Line up for Merck KGaA’s Generics
10:32 AM MDT | July 25, 2007 | Chemical Week Editorial Staff
Private equity capital companies Cinven, Texas Pacific Group, and Permira are among companies that have expressed an interest in acquiring Merck KGaA’s generic drugs business, which is up for sale, according to German press reports last week (CW, Jan. 17, p. 23). Meanwhile, Ranbaxy (Gurgaon, India), India’s biggest manufacturer of pharmaceuticals, says it is considering teaming up with a private equity firm to bid for Merck KGaA’s generics. Pharma manufacturers Actavis (Hafnarfjordur, Iceland) and Sanofi-Aventis may also be interested in buying...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee